301 related articles for article (PubMed ID: 2138076)
1. Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders.
Todd PA; Benfield P
Drugs; 1990 Jan; 39(1):110-35. PubMed ID: 2138076
[TBL] [Abstract][Full Text] [Related]
2. Ramipril: a review of the new ACE inhibitor.
Mills TP
J Ark Med Soc; 1992 Feb; 88(9):437-40. PubMed ID: 1532570
[TBL] [Abstract][Full Text] [Related]
3. Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease.
Deget F; Brogden RN
Drugs; 1991 May; 41(5):799-820. PubMed ID: 1712710
[TBL] [Abstract][Full Text] [Related]
4. Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders.
Todd PA; Fitton A
Drugs; 1991 Jul; 42(1):90-114. PubMed ID: 1718688
[TBL] [Abstract][Full Text] [Related]
5. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor.
Vasmant D; Bender N
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S46-52. PubMed ID: 2483429
[TBL] [Abstract][Full Text] [Related]
6. Ramipril. An updated review of its therapeutic use in essential hypertension and heart failure.
Frampton JE; Peters DH
Drugs; 1995 Mar; 49(3):440-66. PubMed ID: 7774515
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic effects of ramipril and captopril in congestive heart failure.
de Graeff PA; Kingma JH; Viersma JW; Wesseling H; Lie KI
Int J Cardiol; 1989 Apr; 23(1):59-67. PubMed ID: 2523870
[TBL] [Abstract][Full Text] [Related]
8. An open multicenter study to assess the long-term efficacy, tolerance, and safety of the oral angiotensin converting enzyme inhibitor ramipril in patients with mild to moderate essential hypertension.
Bauer B; Lorenz H; Zahlten R
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S70-4. PubMed ID: 2474109
[TBL] [Abstract][Full Text] [Related]
9. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Plosker GL; Sorkin EM
Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology of ramipril.
Ball SG; Robertson JI
Am J Cardiol; 1987 Apr; 59(10):23D-27D. PubMed ID: 3034028
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the efficacy, tolerance, and safety of ramipril in diabetic patients with mild-to-moderate hypertension: a retrospective analysis.
Erhard W; Lindner U; Krall H; Breitstadt A; Pfeiffer C
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S160-4. PubMed ID: 1725032
[TBL] [Abstract][Full Text] [Related]
12. Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders.
Wadworth AN; Brogden RN
Drugs; 1991 Mar; 41(3):378-99. PubMed ID: 1711445
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical and enzyme binding kinetic properties of a new angiotensin-converting enzyme inhibitor ramipril and their clinical implications.
Bender N; Rangoonwala B; Rosenthal J; Vasmant D
Clin Physiol Biochem; 1990; 8 Suppl 1():44-52. PubMed ID: 2147879
[TBL] [Abstract][Full Text] [Related]
14. Comparative double-blind study of ramipril and captopril in mild to moderate essential hypertension.
Witte PU; Walter U
Am J Cardiol; 1987 Apr; 59(10):115D-120D. PubMed ID: 3034018
[TBL] [Abstract][Full Text] [Related]
15. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
[TBL] [Abstract][Full Text] [Related]
16. Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats.
Becker RH; Baldes L; Treudler M
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S35-9. PubMed ID: 2474099
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy and tolerance of ramipril in hypertensive patients with renal failure.
Kindler J; Schunkert H; Gassmann M; Lahn W; Irmisch R; Debusmann ER; Ocón-Pujadas J; Ritz E; Sieberth HG
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S55-8. PubMed ID: 2474105
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension: a multicenter trial.
Mroczek WJ
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S147-9. PubMed ID: 1725028
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
Moursi MG; Ganten D; Lang RE; Unger T
J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591
[TBL] [Abstract][Full Text] [Related]
20. A multi-centre comparative study between ramipril and enalapril in patients with mild to moderate essential hypertension.
Zabludowski J; Rosenfeld J; Akbary MA; Rangoonwala B; Schinzel S
Curr Med Res Opin; 1988; 11(2):93-106. PubMed ID: 2851414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
